A response to “Cannabinoids in Dermatologic Surgery”: The added considerations of factors affecting tissue perfusion, wound healing, and modes of administration in safety and efficacy of cannabinoids

Tasnim Abdalla(University of Toronto), Afsáneh Alavi(Mayo Clinic in Arizona), Asfandyar Mufti(University of Toronto), Katherine McDonald(University of Toronto), Yuliya Lytvyn(University Health Network)
Journal of the American Academy of Dermatology
April 26, 2021
10.1016/j.jaad.2021.04.068
Cited by 2

Related Papers

Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity
|British Journal of Dermatology|2017|467
Diabetic foot ulcers
|Journal of the American Academy of Dermatology|2013|363
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
|The Lancet|2023|318
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment
|American Journal of Clinical Dermatology|2017|314